[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100354888":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":25,"centralContacts":29,"locations":35,"responsibleParty":55,"collaborators":25,"id":59,"slug":60,"hasResults":61,"nctId":62,"briefTitle":63,"officialTitle":64,"acronym":25,"eligibilityCriteria":65,"healthyVolunteers":61,"sex":66,"minAge":67,"maxAge":68,"enrollmentInfo":69,"targetDuration":25,"studyType":72,"phases":73,"briefSummary":75,"conditions":76,"keywords":25,"overallStatus":38,"whyStopped":25,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"Universitaire Ziekenhuizen KU Leuven","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"PGT-A group","EXPERIMENTAL","ovarian stimulation, oocyte aspiration, embryo culture until the blastocyst stage (day 5\u002F6), TE biopsy, vitrification of all embryos in the blastocyst stage, PGT-A by NGS and finally embryo transfer of genetically normal embryos in cumulative frozen-thawed embryo transfer cycles",[13],"Procedure: PGT-A",{"label":15,"type":16,"description":17,"interventionNames":18},"Control group","ACTIVE_COMPARATOR","ovarian stimulation, oocyte aspiration, embryo culture until the blastocyst stage, fresh embryo transfer of the morphologically best embryo on day 5\u002F6, vitrification of supernumerary embryos and embryo transfer in cumulative frozen-thawed embryo transfer cycles if not pregnant from the fresh cycle.",[19],"Procedure: Control",[21,26],{"type":22,"name":23,"description":11,"armGroupLabels":24,"otherNames":25},"PROCEDURE","PGT-A",[9],null,{"type":22,"name":27,"description":17,"armGroupLabels":28,"otherNames":25},"Control",[15],[30],{"name":31,"role":32,"phone":33,"phoneExt":25,"email":34},"Myriam Welkenhuysen","CONTACT","+3216343544","myriam.welkenhuysen@uzleuven.be",[36],{"facility":37,"status":38,"city":39,"state":25,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"UZ Leuven","RECRUITING","Leuven","3000","Belgium","BE",{"type":44,"coordinates":45},"Point",[46,47],4.70093,50.87959,{"lat":47,"lon":46},[50,51],{"name":31,"role":32,"phone":33,"phoneExt":25,"email":34},{"name":52,"role":32,"phone":53,"phoneExt":25,"email":54},"Brecht Geysenbergh, MD","+32496125137","brecht.geysenbergh@uzleuven.be",{"type":56,"investigatorFullName":57,"investigatorTitle":58,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"PRINCIPAL_INVESTIGATOR","Brecht Geysenbergh","Principal Investigator","100354888","preimplantation-genetic-testing-for-aneuploidies-in-patients-with-recurrent-implantation-failure-100354888",false,"NCT03900780","Preimplantation Genetic Testing for Aneuploidies in Patients With Recurrent Implantation Failure","Preimplantion Genetic Testing for Aneuploidies (PGT-A) in Patients With Recurrent Implantation Failure: a Pilot RCT","Inclusion Criteria:\n\n* Women with recurrent implantation failure (previous transfer of least 4 good quality embryos in at least 3 fresh or frozen cycles)\n* BMI \\\u003C 35\n* Normal hysteroscopy\n\nExclusion Criteria:\n\n* thin endometrium in previous cycles (\\\u003C6mm), endometriosis ASRM score III-IV, premature ovarian failure (POF, Bologna criteria), abnormal karyotype, donor oocytes or embryos, PGT-M","FEMALE","18 Years","40 Years",{"count":70,"type":71},100,"ESTIMATED","INTERVENTIONAL",[74],"NA","Assessing whether Preimplantation Genetic Testing for Aneuploidy (PGT-A) can increase the ongoing pregnancy rate per transferred embryo and can decrease the time to pregnancy and miscarriage rate in patients with Recurrent Implantation Failure (RIF)",[77],"Recurrent Implantation Failure","2025-02-25",{"date":80,"type":81},"2025-02-26","ACTUAL",{"date":83,"type":81},"2019-05-01",{"date":85,"type":71},"2026-12-31",{"name":5,"class":6},1]